Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
ID: ALA4245151
Max Phase: Preclinical
Molecular Formula: C59H103N17O9
Molecular Weight: 1194.58
Molecule Type: Small molecule
Associated Items:
ID: ALA4245151
Max Phase: Preclinical
Molecular Formula: C59H103N17O9
Molecular Weight: 1194.58
Molecule Type: Small molecule
Associated Items:
Canonical SMILES: CC(=O)N[C@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCCNC(=N)N)C(=O)N[C@H](C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](CCCNC(=N)N)C(=O)NCCc1c[nH]c2ccccc12)C(C)C
Standard InChI: InChI=1S/C59H103N17O9/c1-33(2)28-45(69-38(11)77)53(81)73-47(30-35(5)6)55(83)75-48(31-36(7)8)56(84)74-46(29-34(3)4)54(82)71-44(22-17-26-67-59(63)64)52(80)76-49(37(9)10)57(85)72-43(20-14-15-24-60)51(79)70-42(21-16-25-66-58(61)62)50(78)65-27-23-39-32-68-41-19-13-12-18-40(39)41/h12-13,18-19,32-37,42-49,68H,14-17,20-31,60H2,1-11H3,(H,65,78)(H,69,77)(H,70,79)(H,71,82)(H,72,85)(H,73,81)(H,74,84)(H,75,83)(H,76,80)(H4,61,62,66)(H4,63,64,67)/t42-,43-,44-,45+,46-,47-,48-,49-/m0/s1
Standard InChI Key: WZULPQILGXKIBC-LMZFJFGWSA-N
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Activity Type | Relation | Activity value | Units | Action Type | Journal | PubMed Id | doi | Assay Aladdin ID |
---|
Natural Product: No | Oral: No | Chemical Probe: No | Parenteral: No |
Molecule Type: Small molecule | Topical: No | First In Class: No | Black Box: No |
Chirality: No | Availability: No | Prodrug: No |
MESH ID | MESH Heading | EFO IDs | EFO Terms | Max Phase for Indication | References |
---|
Mechanism of Action | Action Type | target ID | Target Name | Target Type | Target Organism | Binding Site Name | References |
---|
Molecular Weight: 1194.58 | Molecular Weight (Monoisotopic): 1193.8125 | AlogP: | #Rotatable Bonds: |
Polar Surface Area: | Molecular Species: | HBA: | HBD: |
#RO5 Violations: | HBA (Lipinski): | HBD (Lipinski): | #RO5 Violations (Lipinski): |
CX Acidic pKa: | CX Basic pKa: | CX LogP: | CX LogD: |
Aromatic Rings: | Heavy Atoms: | QED Weighted: | Np Likeness Score: |
1. Dianati V, Kwiatkowska A, Couture F, Desjardins R, Dory YL, Day R.. (2018) Increasing C-Terminal Hydrophobicity Improves the Cell Permeability and Antiproliferative Activity of PACE4 Inhibitors against Prostate Cancer Cell Lines., 61 (18): [PMID:30180568] [10.1021/acs.jmedchem.8b01144] |
Source(1):